Neonatal onset multisystem inflammatory disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "#redirest Cryopyrin-associated periodic syndrome")
Tag: Replaced
 
Line 1: Line 1:
__NOTOC__
#redirest [[Cryopyrin-associated periodic syndrome]]
{{Infobox_Disease |
| Name          = Neonatal onset multisystem inflammatory disease
| Image          =
| Caption        =
| DiseasesDB    = 32178
| OMIM          = 607115
| MedlinePlus    =
| MeshID        =
}}
 
{{SI}}
{{CMG}}
 
{{SK}} NOMID; chronic neurologic cutaneous and articular syndrome; CINCA; CINCA syndrome; cryopyrin- associated periodic syndrome 3; CAPS3; neonatal-onset multisystemic inflammatory disease; chronic infantile neurological, cutaneous and articular syndrome
==Overview==
'''Neonatal onset multisystem inflammatory disease''' (also known as '''NOMID''', '''Chronic Neurologic Cutaneous and Articular Syndrome''', or '''CINCA''') is a [[rare disease|rare]] genetic [[periodic fever syndrome]] which causes uncontrolled inflammation in multiple parts of the body starting in the newborn period. Symptoms include skin rashes, severe [[arthritis]], and chronic [[meningitis]] leading to neurologic damage.
 
NOMID can result from a mutation in the [[CIAS1]] gene, which helps control inflammation. Mutations in this gene also cause [[familial cold urticaria]] and [[Muckle-Wells syndrome]]. NOMID has been successfully treated with the drug [[anakinra]].
 
==References==
*{{OMIM|607115}}
* Goldbach-Mansky, R. et al. ''Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1{beta} Inhibition'' N Engl J Med 2006 355: 581-592.
 
[[Category:Rheumatology]]
 
{{WH}}
{{WikiDoc Sources}}

Latest revision as of 13:38, 30 July 2019